Latest1 information on COVID-19

Clinical Trials Contact

About this Clinical Trial

Clinical Trial of a Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies

Your Message Will Go To

Elizabeth Winters

650-721-6509


All fields are required. *

Preferred contact method*

To:

Elizabeth Winters

650-721-6509



Go Back To The Trial

We were not able to send your contact info at this time.

Go Back To The Trial

©2022 Stanford Medicine